Back to Agenda
Creating a Favourable Environment for Advanced Therapy Medicinal Products (ATMPs)
Session Chair(s)
Eduardo Bravo
Chief Executive Officer
Tigenix, Belgium
Creating a Favourable Environment for Advanced Therapy Medicinal Products (ATMPs)
Speaker(s)
Improving the Regulatory Environment for ATMPs in Europe
Paula Salmikangas, PhD
NDA Group, United Kingdom
Advisory Board, Director of Biopharmaceuticals and ATMPs
Reimbursement Challenges Facing ATMPs
Deborah Morrison
National Institute for Health and Care Excellence (NICE), United Kingdom
Senior Scientific Adviser
Existing Barriers for the Commercial Success of ATMPs
Andrea Chiesi
Chiesi Farmaceutici, Italy
Director R&D Project and Portfolio Management
Have an account?